Osteoporosis - An update

Journal of the Nepal Medical Association

Volumn 44, Issue 158, 2005, Pages 60-66

  Lamichhane, Arjun Prasad ^a  

^a TRIBHUVAN UNIVERSITY TEACHING HOSPITAL   (Nepal)

Author keywords

Bone mineral density; Fracture; Menopause; Osteoporosis

Indexed keywords

ALENDRONIC ACID; CALCITONIN; CALCIUM; ESTROGEN; FLUORIDE; PARATHYROID HORMONE; PYROPHOSPHORIC ACID DERIVATIVE; RISEDRONIC ACID; VITAMIN D;

ALCOHOL CONSUMPTION; ALLERGY; BONE DENSITOMETRY; BONE DENSITY; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FLUSHING; FRAGILITY FRACTURE; GASTROINTESTINAL SYMPTOM; HUMAN; LABORATORY TEST; LIFESTYLE; MENOPAUSE; META ANALYSIS; NONHUMAN; NOSE IRRITATION; OSTEOLYSIS; OSTEOPOROSIS; PAIN; REVIEW; RISK FACTOR; SKELETON MALFORMATION; SMOKING; SYSTEMATIC REVIEW; ULTRASOUND; X RAY FILM;

EID: 33645398560     PISSN: 00282715     EISSN: None     Source Type: Journal    
DOI: 10.31729/jnma.404     Document Type: Review

References (39)

1. National Institute of Health. Osteoporosis prevention, diagnosis, and therapy. Consensus Statement. Bethesda, MD: National Institutes of Health; 2000; 17:1-36.
2. Haczynski J, Jakimiuk A. Vertebral fractures: A hidden problems of osteoporosis. Med Sci monit 2001; 7: 1108-17.
3. Goddard D, Kleerekoper M. The epidemiology of osteoporosis. Post Grad. Medicine, 1988; 104:54-70.
4. Mary L. Bouxsein, John Kaufman, Laura Tosi, Steven Cummings, Joseph Lane, and Olof Johnell. Recommendations for Optimal Care of the Fragility Fracture Patient to Reduce the Risk of Future Fracture. J Am Acad Orthop Surg. 2004; 12(6): 385-395
5. Hurley DL, Khosla S: Update on primary osteoporosis. Mayo Clin Proc, 1977; 72: 943-949.
6. Off SM. Osteoporosis and Osteomalacia. In: Hazzard WR, Blass JP, Ettinger WH, Halter JB, Ouslander JG, Editors. Principle of Geriatric Medicine and Gerontology. New York: McGraw - Hill; 1999, 1057-1080.
7. Holland EFN, Stud JWW, Mansell JP et al. Changes in the collagen composition and cross-link in bone and skin of osteporotic post-menopausal women treated with percutaneous estradiol implants. Obstet Gynecol, 1994; 83: 180-3.
8. Goodman TA, Simon LS. Osteoporosis: Current issue in diagnosis and management. J Musculoskel Med. 1997; 14: 10-22.
9. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ III. Incidence of clinically diagnosed vertebral fractures: A population based study in Rochester, Minnesota, 1985-1989. J Bone Min Res. 1992; 7: 221-227.
10. Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001; 285: 320-323.
11. Nevitt MC, Ross PD, Palermo L, Musliner T, Genant HK, Thompson DE. Association of prevalent fractures, bone density, and alendronate treatment with incident vertebral fractures: Effect of number and spinal location of fractures. Bone. 1999; 25: 613-619.
12. Melton LJ III, Chrischilles EA, Cooper C, Lane AW, Riggs BL: Perspective: How many women have osteoporosis? J Bone Miner Res 1992; 7: 1005-1010.
13. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA: Mortality after all major types of osteoporotic fracture in men and women: An observational study. Lancet 1999; 353: 878-882.
14. Black DM, Cummings SR, Karpf DB, et al: Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group. Lancet 1996; 348: 1535-1541.
15. Leidig G, Minne HW, Saur P, et al. A study of complains and their relation to vertebral destruction in patients with osteoporosis. Bone Miner. 1990; 8: 217-219.
16. Cook DJ, Guyatt GH, Adachi JD, et al. Quality of life issue in women with vertebral fractures due to osteoporosis. Arth Rheum. 1993; 36: 750-756.
17. Ryan PJ, Blake G, Herd R, Fogelman I. A clinical profile of back pain and disability in patients with spinal osteoporosis. Bone. 1994; 15: 27-30.
18. Van Staa TP, Leufkens HG, Cooper C: Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int 2002; 13: 624-629.
19. Miller PD, Siris ES, Barret-Conner E, et al. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: Evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res. 2002; 17: 2222-2230.
20. The European Prospective Osteoporosis Study Group. The relationship between bone density and incident vertebral fracture in women and men. J Bone Miner Res. 2002; 17: 2214-2221.
21. Eddy D, Johnston C, Cummings SR, et al. Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost effective analysis. Osteoporosis Int. 1998; 8(suppl4): S7-S80.
22. Kleerekoper M, Nelson DA. Which bone density measurement? J Bone Miner Res. 1997; 12: 712-714.
23. Heaney RP, Avioli LV, Chesnut CH, III, Lappe J, Recker RR, Brandenburger GH. Ultrasound velocity through bone predicts incident vertebral deformity. J Bone Miner Res. 1995; 10: 341-345.
24. Lambing CL. Osteoporosis 2003. Program and abstracts of the American Academy of Family Physicians 2003 Annual Scientific Assembly; October 1-5, 2003; New Orleans, Louisiana. Abstract 181.
25. Riggs BL, Melto LJ. The prevention and treatment of osteoporosis. N Eng J Med 1992; 327: 622-626.
26. Varga M. Osteoporosis: Strategies for prevention and treatment. J Musculoskel Med 1995; 12: 19-30.
27. Lambing CL. Osteoporosis 2003. Program and abstracts of the American Academy of Family Physicians 2003 Annual Scientific Assembly; October 1-5, 2003; New Orleans, Louisiana. Abstract 181.
28. Apgar BS. HRT dilemma. Program and abstracts of the American Academy of Family Physicians 2003 Annual Scientific Assembly; October 1-5, 2003; New Orleans, Louisiana. Abstract 12.
29. Hays J, Ockene JK, Brunner RL, et al, for the Women's Health Initiative Investigators. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 2003; 348: 1839-1854.
30. Langer RD. Postmenopausal hormone therapy: the state-of-the-art 2003. Program and abstracts of the American Academy of Family Physicians 2003 Annual Scientific Assembly; October 1-5, 2003; New Orleans, Louisiana. Abstract, 567.
31. Rossouw JE, Anderson GL, Prentice RL, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
32. Wells G, Tugwell P, Shea B, et al: Metaanalyses of therapies for postmenopausal osteoporosis: V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev, 2002; 23: 529-539.
33. Torgerson DJ, Bell-Syer SE: Hormone replacement therapy and prevention of nonvertebral fractures: A meta-analysis of randomized trials. JAMA 2001; 285: 2891-2897.
34. Chestnut CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in post-menopausal women with established osteoporosis: the prevention of recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med. 2000; 109:267-276.
35. Black DM, Cummings SR, Karpf DB, et al: Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group. Lancet 1996; 348: 1535-1541.
36. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C: Meta-analyses of therapies for postmenopausal osteoporosis: IX. Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 2002; 23: 570-578.
37. Harris ST, Watts NB, Genant HK, et al: Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA, 1999; 282: 1344-1352.
38. McClung MR, Geusens P, Miller PD, et al: Effect of risedronate on the risk of hip fracture in elderly women: Hip Intervention Program Study Group. N Engl J Med 2001; 344: 333-3.
39. Neer RM, Arnaud CD, Zanchetta JR, et al: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-1441.